GKOS Glaukos
- 99.480
- 0.0000.00%
Glaukos News
The Price Is Right For Glaukos Corporation (NYSE:GKOS)
When close to half the companies in the Medical Equipment industry in the United States have price-to-sales ratios (or "P/S") below 3.1x, you may consider Glaukos Corporation (NYSE:GKOS) as a stock to
Glaukos Announces the Release of Its 2023 Sustainability Report
Glaukos Corporation (NYSE:GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that it has
Express News | Glaukos Corp : Truist Securities Raises Target Price to $120 From $110
Needham Sees BSX, CNMD, RMD Beating Street, Despite Medtech Slow Down
Glaukos (GKOS) Gains Nearly 25% YTD: What's Driving the Rally?
Is Now The Time To Look At Buying Glaukos Corporation (NYSE:GKOS)?
Glaukos Insider Sold Shares Worth $6,008,359, According to a Recent SEC Filing
Joseph E Gilliam, PRESIDENT & COO, on April 08, 2024, sold 59,801 shares in Glaukos (GKOS) for $6,008,359. Following the Form 4 filing with the SEC, Gilliam has control over a total of 101,845 shares
Glaukos Is Maintained at Neutral by Mizuho
Glaukos Is Maintained at Neutral by Mizuho
Express News | Glaukos Corp : Mizuho Raises Target Price to $100 From $85
Glaukos(GKOS.US) Officer Sells US$6.01 Million in Common Stock
$Glaukos(GKOS.US)$ Officer Gilliam Joseph E sold 59,801 shares of common stock on Apr 8, 2024 at an average price of $100.47 for a total value of $6.01 million.Source: Announcement What is statement o
Glaukos to Release First Quarter 2024 Financial Results After Market Close on May 1
Glaukos(GKOS.US) Officer Sells US$163.26K in Common Stock
$Glaukos(GKOS.US)$ Officer Thurman Alex R. sold 1,634 shares of common stock on Apr 5, 8, 2024 at an average price of $99.91 for a total value of $163.26K.Source: Announcement What is statement of cha
Glaukos(GKOS.US) Officer Sells US$237.86K in Common Stock
$Glaukos(GKOS.US)$ Officer Gilliam Joseph E sold 2,457 shares of common stock on Apr 5, 2024 at an average price of $96.81 for a total value of $237.86K.Source: Announcement What is statement of chang
Form 144 | Glaukos(GKOS.US) Officer Proposes to Sell 137.95K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 8, $Glaukos(GKOS.US)$ Officer Thurman Alex R. intends to sell 1,372 shares of its common stock on Apr 8, with a total market value of approximately $137.95K. Thurman Alex
Form 144 | Glaukos(GKOS.US) Officer Proposes to Sell 7.54 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 8, $Glaukos(GKOS.US)$ Officer Gilliam Joseph E intends to sell 75,000 shares of its common stock on Apr 8, with a total market value of approximately $7.54 million. Gilli
Truist Securities Reiterates Buy on Glaukos, Maintains $110 Price Target
Truist Securities analyst Samuel Brodovsky reiterates Glaukos with a Buy and maintains $110 price target.
Glaukos(GKOS.US) Officer Sells US$38,636 in Common Stock
$Glaukos(GKOS.US)$ Officer Gilliam Joseph E sold 400 shares of Common Stock on Apr 3, 4, 2024 at an average price of $96.59 for a total value of $38,636.Source: Announcement What is statement of chang
Glaukos(GKOS.US) Officer Sells US$71,271.12 in Common Stock
$Glaukos(GKOS.US)$ Officer Thurman Alex R. sold 750 shares of Common Stock on Apr 3, 4, 2024 at an average price of $95.03 for a total value of $71,271.12.Source: Announcement What is statement of cha
Form 144 | Glaukos(GKOS.US) Officer Proposes to Sell 237.85K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 5, $Glaukos(GKOS.US)$ Officer Gilliam Joseph E intends to sell 2,457 shares of its common stock on Apr 5, with a total market value of approximately $237.85K. Gilliam Jos
Sector Update: Health Care Stocks Rise Wednesday Afternoon
Health care stocks were advancing Wednesday afternoon, with the NYSE Health Care Index adding 0.3% and the Health Care Select Sector SPDR Fund (XLV) up 0.2%. The iShares Biotechnology ETF (IBB) decrea
Analysis
Price Target
No Data
